Disease recurrence and oncological outcome of patients treated surgically with curative intent for estrogen receptor positive, lymph node negative breast cancer

325 PUBLICATION Prognostic relevance of HER2 expression and gene amplification in estrogen receptor-positive lymph-node negative breast cancer patients

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)80623-8 ◽

2005 ◽

Vol 3 (2) ◽

pp. 91

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Lymph Node ◽

Cancer Patients ◽

Positive Lymph Node ◽

Her2 Expression ◽

Breast Cancer Patients ◽

Node Negative ◽

MEMORANDUM FOR: Science Writers and Editors on the Journal Press List: 5 Years of Tamoxifen After Surgery Is Adequate for Women With Estrogen Receptor-Positive, Lymph Node-Negative Breast Cancer

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/93.9.661-a ◽

2001 ◽

Vol 93 (9) ◽

pp. 661-661

Author(s):

K. Arnold ◽

D. Eckstein

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Lymph Node ◽

Positive Lymph Node ◽

Node Negative ◽

Factors That Predict Biological Aggressiveness in Estrogen Receptor–Positive / Human Epidermal Growth Factor Receptor 2–Negative / Lymph Node–Negative Breast Cancer

Ochsner Journal ◽

10.31486/toj.20.0035 ◽

2020 ◽

Vol 20 (4) ◽

pp. 381-387

Author(s):

Lauren E. Arthur ◽

Ashley H. McMann ◽

Lauren N. Slattery ◽

George M. Fuhrman ◽

Aimee M. Mackey ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Epidermal Growth Factor Receptor ◽

Lymph Node ◽

Growth Factor ◽

Growth Factor Receptor ◽

Node Negative ◽

Estrogen Receptor Positive ◽

Epidermal Growth

P4-02-06: Progesterone Receptor Expression Predicts Poor Outcome in Estrogen Receptor Positive, Lymph Node Negative Breast Cancer – A Population Based Study.

10.1158/0008-5472.sabcs11-p4-02-06 ◽

2011 ◽

Author(s):

CA Purdie ◽

P Quinlan ◽

LB Jordan ◽

A Ashfield ◽

L Baker ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Population Based ◽

Positive Lymph Node ◽

Receptor Expression ◽

Progesterone Receptor Expression ◽

Population Based Study ◽

Node Negative ◽

Prediction of Low versus High Recurrence Scores in Estrogen Receptor–Positive, Lymph Node–Negative Invasive Breast Cancer on the Basis of Radiologic-Pathologic Features: Comparison with Oncotype DX Test Recurrence Scores

Radiology ◽

10.1148/radiol.2016151149 ◽

2016 ◽

Vol 280 (2) ◽

pp. 370-378 ◽

Cited By ~ 24

Author(s):

Vandana Dialani ◽

Shantanu Gaur ◽

Tejas S. Mehta ◽

Shambhavi Venkataraman ◽

Valerie Fein-Zachary ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Lymph Node ◽

Invasive Breast Cancer ◽

Positive Lymph Node ◽

Oncotype Dx ◽

Node Negative ◽

Pathologic Features ◽

Societal cost-effectiveness analysis of the 21-gene assay in estrogen-receptor–positive, lymph-node–negative early-stage breast cancer in Japan

BMC Health Services Research ◽

10.1186/1472-6963-14-372 ◽

2014 ◽

Vol 14 (1) ◽

Cited By ~ 10

Author(s):

Hideko Yamauchi ◽

Chizuko Nakagawa ◽

Shinji Yamashige ◽

Hiroyuki Takei ◽

Hiroshi Yagata ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Lymph Node ◽

Early Stage ◽

Positive Lymph Node ◽

Societal Cost ◽

Node Negative ◽

Effectiveness Analysis ◽

Gene Assay ◽

Abstract P6-08-10: Prospective study of the impact of the Prosigna™ assay on adjuvant clinical decision-making in women with estrogen receptor-positive, HER2-negative, node-negative breast cancer: A GEICAM study

10.1158/1538-7445.sabcs14-p6-08-10 ◽

2015 ◽

Cited By ~ 1

Author(s):

Miguel Martín ◽

Milagros González-Rivera ◽

Serafín Morales ◽

Juan de la Haba ◽

Lucía González-Cortijo ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Estrogen Receptor ◽

Prospective Study ◽

Clinical Decision Making ◽

Clinical Decision ◽

Node Negative ◽

Estrogen Receptor Positive ◽

The Impact

Abstract P2-08-01: Prospective trial of endocrine therapy alone in patients with estrogen receptor positive, HER2-negative, node-negative breast cancer: Results of the TAILORx low risk registry

10.1158/1538-7445.sabcs15-p2-08-01 ◽

2016 ◽

Cited By ~ 1

Author(s):

JA Sparano ◽

RJ Gray ◽

DF Makower ◽

KI Pritchard ◽

KS Albain ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Endocrine Therapy ◽

Prospective Trial ◽

Low Risk ◽

Node Negative ◽

Abstract P4-08-27: The 21-gene Recurrence® (RS) Score assay in estrogen receptor positive node negative breast cancer: Real-world chemotherapy usage and patient characteristics within the intermediate and high-risk RS category

10.1158/1538-7445.sabcs18-p4-08-27 ◽

2019 ◽

Author(s):

D Le ◽

S Chia ◽

C Simmons ◽

C Speers ◽

L Gondara ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

High Risk ◽

Real World ◽

Patient Characteristics ◽

Positive Node ◽

Node Negative ◽

Economic analysis of targeting chemotherapy (CT) using a 21 gene RT-PCR assay in lymph node negative (LN-), estrogen receptor positive (ER+) early-stage breast cancer (ESBC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.6036 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 6036-6036

Author(s):

L. E. Cosler ◽

J. Hornberger ◽

G. H. Lyman

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Lymph Node ◽

Economic Analysis ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Rt Pcr ◽

Pcr Assay ◽

Node Negative ◽